Is GlobalFoundries On The Verge Of A Breakout?
GLOBALFOUNDRIES Inc. (NASDAQ:GFS) is as a semiconductor foundry whose chips…
Sell
40
SUPN Quote, Financials, Valuation and Earnings
Last price:
$33.08
Seasonality move
:
11.77%
Day range:
$32.83 - $33.49
52-week range:
$25.53 - $40.28
Dividend yield:
0%
P/E ratio:
29.91x
P/S ratio:
2.78x
P/B ratio:
1.80x
Volume:
488.7K
Avg. volume:
461.5K
1-year change:
15.4%
Market cap:
$1.9B
Revenue:
$661.8M
EPS (TTM):
$1.11
SUPN Analysts' Consensus Rating
The 5 analysts providing 12-month price projections for Supernus Pharmaceuticals shares anticipate an average target of $38.80, ranging from a low estimate of $36.00 to a high estimate of $44.00. This average target implies a growth of 16.87% compared to the current stock price of $33.20.
Consensus Price Target
$38.80
Highest Price Target
$44.00
Lowest Price Target
$36.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 2 | 2 | 2 |
| Hold | 2 | 3 | 3 |
| Sell | 0 | 0 | 0 |
| Consensus | Leans Bullish | Hold | Hold |
SUPN Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Dick’s Sporting Goods Buying Foot Locker Smart?
Last week, Dick’s Sporting Goods (NYSE:DKS) announced that it would…
Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Alerts
Buy
55
RGC alert for May 21
Regencell Bioscience Holdings [RGC] is down 9.91% over the past day.
Buy
64
AKRO alert for May 21
Akero Therapeutics [AKRO] is up 0.67% over the past day.
Buy
76
AGYS alert for May 21
Agilysys [AGYS] is down 0.26% over the past day.
